title: Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome.
authors.affiliation: Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Do Wook
authors.initials: DW
authors.lastname: Kim
authors.affiliation: Eyereum Ophthalmic Clinic, Seoul, Korea.
authors.forename: Sung Yong
authors.initials: SY
authors.lastname: Kang
authors.affiliation: Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Hyoung Won
authors.initials: HW
authors.lastname: Bae
authors.affiliation: Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Samin
authors.initials: S
authors.lastname: Hong
authors.affiliation: Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Gong Je
authors.initials: GJ
authors.lastname: Seong
authors.affiliation: Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Chan Yun
authors.initials: CY
authors.lastname: Kim
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D058449:Intravitreal Injections; D009898:Optic Disk / Q000473:pathology*; D016878:POEMS Syndrome / Q000150:complications* / Q000175:diagnosis; D010211:Papilledema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab